Your browser doesn't support javascript.
loading
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro.
Kauer, Joseph; Märklin, Melanie; Pflügler, Martin; Hörner, Sebastian; Hinterleitner, Clemens; Tandler, Claudia; Jung, Gundram; Salih, Helmut R; Heitmann, Jonas S.
Afiliación
  • Kauer J; Departament of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
  • Märklin M; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.
  • Pflügler M; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
  • Hörner S; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
  • Hinterleitner C; DFG Cluster of Excellence 2180 'Image-Guided and Functional Instructed Tumor Therapy' (IFIT), University of Tübingen, Tübingen, Germany.
  • Tandler C; Departament of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
  • Jung G; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany.
  • Salih HR; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany.
  • Heitmann JS; Departament of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.
J Cancer Res Clin Oncol ; 148(10): 2759-2771, 2022 Oct.
Article en En | MEDLINE | ID: mdl-35551463

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas de Fusión bcr-abl / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas de Fusión bcr-abl / Leucemia-Linfoma Linfoblástico de Células Precursoras Límite: Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: Alemania